Dianthus Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
24.00
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-09-30
|
-0.56
|
-3.78
|
-3.22
|
-575.00%
|
|
2023-06-30
|
-3.04
|
-0.87
|
2.17
|
71.50%
|
|
2023-03-31
|
-0.40
|
-0.47
|
-0.07
|
-17.50%
|
|
2022-12-31
|
-0.28
|
-0.30
|
-0.02
|
-8.62%
|
|
2022-09-30
|
-0.29
|
-0.27
|
0.02
|
6.90%
|
|
2022-06-30
|
-0.34
|
-0.29
|
0.05
|
14.71%
|
|
2022-03-31
|
-0.32
|
-0.39
|
-0.07
|
-22.60%
|
|
2021-12-31
|
-0.32
|
-0.33
|
-0.01
|
-4.13%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2023-12-31
|
-5.12
|
|
2022-12-31
|
-1.25
|
|
2021-12-31
|
-1.31
|
|
2020-12-31
|
-1.74
|
|
2019-12-31
|
-2.05
|
|
2018-12-31
|
-8.57
|
|
2017-12-31
|
-1.18
|